Lipoproteins and Atherosclerosis

Front Matter....Pages i-x
Heterogeneity of Apolipoprotein B Containing Lipoproteins....Pages 1-5
Separation and Identification of APO-B-Containing Lipoprotein Particles in Normolipidemic Subjects and Patients with Hyperlipoproteinemias....Pages 7-14
HDL Subfractions, HDL Receptors and HDL Turnover....Pages 15-21
Use of Monoclonal Antibodies to Human Apo A–I in the Determination of Antigenic Sites Present on HDL Surface....Pages 23-30
Epitope Expression in Purified and Lipid-Bound forms of Human Apoprotein A–I....Pages 31-35
Apolipoprotein D, Monoclonal Antibodies, and Cross-Reacting Proteins....Pages 37-40
Characterisation and Mode of Inheritance of Apolipoprotein E3-Leiden....Pages 41-45
Results of the Study of Apolipoprotein E and its Isomorphs on Isoelectric Focusing in Dyslipoproteinemias....Pages 47-53
Ag System Re-Explored: Studies with Monoclonal Anti-Apolipoprotein B Antibodies....Pages 55-62
Use of Combined Monoclonal Antibodies for the Immunochemical Determination of Apolipoproteins A–I and B in Human Plasma....Pages 63-71
Mechanism of Action of Lipoprotein Lipase and Hepatic Triglyceride Lipase....Pages 73-77
The Role of LCAT and Cholesteryl Ester Transfer Proteins for the HDL and LDL Structure and Metabolism....Pages 79-86
Cholesteryl Ester Transfer in Atherosclerosis....Pages 87-93
Metabolism of Apolipoprotein C: Kinetic Studies in Human Subjects: A Critical Review....Pages 95-103
Turnover and Interconversion of LDL Sub-Fractions....Pages 105-109
Metabolic Determinants of Plasma High-Density Lipoprotein Concentration in Humans....Pages 111-115
Lipid Metabolism and the Enterohepatic Circulation: The Regulatory Functions of HMG CoA Reductase and Cholesterol 7∝ Hydroxylase....Pages 117-122
The Role of the LDL Receptor in Lipoprotein Metabolism....Pages 123-130
The Uptake of Chylomicron Remnants by the Liver....Pages 131-135
The Receptor-Mediated Interaction of Lipoproteins with Liver Cells....Pages 137-144
Disposal of HDL-Cholesterol to Cultured Granulosa Cells, Endothelial Cells and Hepatocytes: Effects of HDL-Phospholipolysis....Pages 145-151
Effects of Dietary Fat Modifications on Plasma Lipid and Apolipoprotein Metabolism in Humans....Pages 153-158
Effects of Diet Fat P/S Ratio on Serum Lipoprotein Concentrations....Pages 159-163
Diet and HDL Metabolism: High Carbohydrate vs. High Fat Diets....Pages 165-172
The Effects of Diet, Acute Exercise and Regular Training on Muscle Lipoprotein Lipase Activity....Pages 173-181
Changes in Serum Lipoproteins and in Lecithin: Cholesterol Acyltransferase Activity with Dietary Fat Modification....Pages 183-187
Cultured Fibroblast Interactions with LDL and HDL from Healthy Subjects on Various Dietary Fats....Pages 189-194
Beta-Blocking Agents and Plasma Lipids: An Update....Pages 195-200
Apolipoproteins Induced by an Antimitotic Agent....Pages 201-208
Meaning of a Modified LDL in Humans....Pages 209-212
Latent Type IV....Pages 213-218
HDL and Coronary Heart Disease: A Familial Trend....Pages 219-224
Molecular Analysis of Lipoproteins: Clinical Applications....Pages 225-231
Platelet Fibrinogen Binding in Familial Hypercholesterolemia....Pages 233-236
Studies on the Correlation Between the Quantity of LDL-Binding Sites of Platelets and the Serum Cholesterol Levels....Pages 237-244
Back Matter....Pages 245-256